{
    "title": "British drug giant AstraZeneca suffers from research criticising second best-selling product",
    "url": "https://www.dailymail.co.uk/money/article-1199323/British-drug-giant-AstraZeneca-suffers-research-showing.html",
    "date": "2009-07-13",
    "keywords": [
        "clozapine",
        "treatment",
        "drug",
        "astrazeneca",
        "seroquel",
        "risk",
        "percent",
        "giant",
        "product",
        "schizophrenia",
        "leader",
        "clozaril",
        "use",
        "spokeswoman",
        "company",
        "share",
        "research",
        "gmt",
        "july",
        "view",
        "medicine",
        "market",
        "journal",
        "lancet",
        "suicide",
        "finding",
        "novartis",
        "generation",
        "health",
        "safety",
        "blood",
        "resolution",
        "bid",
        "rejection",
        "article",
        "analysis",
        "finland",
        "firstgeneration",
        "death",
        "contrast",
        "mortality",
        "quetiapine",
        "johnson",
        "resperidone",
        "zyprexa",
        "olanzapinewe",
        "efficacy",
        "study",
        "tiihonen",
        "university",
        "kuopio",
        "telephone",
        "interviewwe",
        "firstline",
        "optionan",
        "illnessschizophrenia",
        "disorder",
        "experience"
    ],
    "category": [
        "money"
    ]
}